The FDA issued a complete response letter for SYD-101, citing insufficient evidence of effectiveness despite achieving ...

Yuflyma (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications – adolescent ...

Kids with a rare bone cancer called Ewing sarcoma might live longer if prescribed pazopanib, a drug that blocks blood supply ...

Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found that under a quarter of children with multi-metastatic Ewing sarcoma ...

Key Takeaways An already approved drug might help kids with a rare bone cancerPazopanib extended survival in a small group of ...

Watch as Gabe Fholer rings the bell to celebrate being cancer-free. Doctors say a breakthrough drug helped make it happen.